If there is contamination in products intended to be sterile, patients are at risk of serious infections which may be life threatening. The company has not received any reports of product contamination or adverse events to date.
The recalled products were made from July 21, 2014, through July 21, 2015, and dispensed to patients or distributed to physicians for further administering to patients [in] Arizona, Idaho, Florida, Oregon, Texas and Washington. All recalled products have a label that includes the pharmacy name and the name of the compounded drug product.
The following unexpired lots of sterile compounded products are being recalled…
BUPRENORPHINE MULTIDOSE VIAL 0.3MG/ML INJ SOLN